These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17885627)

  • 1. Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7.
    Rotger M; Saumoy M; Zhang K; Flepp M; Sahli R; Decosterd L; Telenti A;
    Pharmacogenet Genomics; 2007 Oct; 17(10):885-90. PubMed ID: 17885627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
    Lang T; Klein K; Fischer J; Nüssler AK; Neuhaus P; Hofmann U; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenetics; 2001 Jul; 11(5):399-415. PubMed ID: 11470993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping.
    Jacob RM; Johnstone EC; Neville MJ; Walton RT
    Clin Chem; 2004 Aug; 50(8):1372-7. PubMed ID: 15178651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.
    Rotger M; Tegude H; Colombo S; Cavassini M; Furrer H; Décosterd L; Blievernicht J; Saussele T; Günthard HF; Schwab M; Eichelbaum M; Telenti A; Zanger UM
    Clin Pharmacol Ther; 2007 Apr; 81(4):557-66. PubMed ID: 17235330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of single nucleotide polymorphisms in CYP2B6 gene.
    Zanger UM; Fischer J; Klein K; Lang T
    Methods Enzymol; 2002; 357():45-53. PubMed ID: 12424896
    [No Abstract]   [Full Text] [Related]  

  • 6. Q172H replacement overcomes effects on the metabolism of cyclophosphamide and efavirenz caused by CYP2B6 variant with Arg262.
    Ariyoshi N; Ohara M; Kaneko M; Afuso S; Kumamoto T; Nakamura H; Ishii I; Ishikawa T; Kitada M
    Drug Metab Dispos; 2011 Nov; 39(11):2045-8. PubMed ID: 21821736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel single nucleotide polymorphisms (SNPs) of the CYP2B6 gene in Japanese individuals.
    Hiratsuka M; Hinai Y; Konno Y; Nozawa H; Konno S; Mizugaki M
    Drug Metab Pharmacokinet; 2004 Apr; 19(2):155-8. PubMed ID: 15499182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.
    Desta Z; Saussele T; Ward B; Blievernicht J; Li L; Klein K; Flockhart DA; Zanger UM
    Pharmacogenomics; 2007 Jun; 8(6):547-58. PubMed ID: 17559344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.
    Puthanakit T; Tanpaiboon P; Aurpibul L; Cressey TR; Sirisanthana V
    Antivir Ther; 2009; 14(3):315-20. PubMed ID: 19474465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.
    Faucette SR; Zhang TC; Moore R; Sueyoshi T; Omiecinski CJ; LeCluyse EL; Negishi M; Wang H
    J Pharmacol Exp Ther; 2007 Jan; 320(1):72-80. PubMed ID: 17041008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of CYP2B6 cDNA in cynomolgus macaques (Macaca fascicularis).
    Uno Y; Matsuno K; Nakamura C; Utoh M; Yamazaki H
    J Vet Med Sci; 2009 Dec; 71(12):1653-6. PubMed ID: 20046035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.
    Gatanaga H; Hayashida T; Tsuchiya K; Yoshino M; Kuwahara T; Tsukada H; Fujimoto K; Sato I; Ueda M; Horiba M; Hamaguchi M; Yamamoto M; Takata N; Kimura A; Koike T; Gejyo F; Matsushita S; Shirasaka T; Kimura S; Oka S
    Clin Infect Dis; 2007 Nov; 45(9):1230-7. PubMed ID: 17918089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients.
    Habtewold A; Amogne W; Makonnen E; Yimer G; Riedel KD; Ueda N; Worku A; Haefeli WE; Lindquist L; Aderaye G; Burhenne J; Aklillu E
    J Antimicrob Chemother; 2011 Oct; 66(10):2350-61. PubMed ID: 21846671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools.
    Radloff R; Gras A; Zanger UM; Masquelier C; Arumugam K; Karasi JC; Arendt V; Seguin-Devaux C; Klein K
    Hum Mutat; 2013 May; 34(5):725-34. PubMed ID: 23418033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
    Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
    Back DJ; Owen A; Khoo SH
    Clin Pharmacokinet; 2006; 45(2):213-4; author reply 214-5. PubMed ID: 16485918
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Drug Metabol Drug Interact; 2002; 19(2):115-35. PubMed ID: 12751910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.
    Hiratsuka M; Takekuma Y; Endo N; Narahara K; Hamdy SI; Kishikawa Y; Matsuura M; Agatsuma Y; Inoue T; Mizugaki M
    Eur J Clin Pharmacol; 2002 Sep; 58(6):417-21. PubMed ID: 12242601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.